Information Library

Results for: White Papers - High-quality studies

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • An Integrated Approach to Biosimilar Development & Commercialization

    September 29, 2011
    As the market for biosimilar products continues to grow, many biopharmaceutical companies trying to enter the space are struggling to overcome the unique challenges that developing such products presents.

  • Methods Matter

    July 18, 2011
    As healthcare decision making becomes more complex, stakeholders are demanding real-world evidence tailored to their own individual needs.

  • The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer

    June 23, 2011
    In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance.

  • CardioCheck

    May 10, 2011
    Quintiles' CardioCheck program is designed to provide rapid insight into potential cardiotoxic influences of pharmaceutical compounds.

  • Asia

    March 8, 2011
    This paper examines new development models as Western companies seek to develop and register their products in Asia, while emerging Asian companies seek new capabilities to globalize products.

  • Clinical Endpoint Committees - Summary

    March 6, 2011
    What are regulatory boards looking for in clinical endpoint committees? Read our executive summary on the current best practice across the industry.

  • Clinical Endpoint Committees

    February 22, 2011
    As regulatory boards are expecting more from clinical endpoint committees, what guidance can you follow? This white paper sets forth current best practice for CECs.

  • Is a REMS Request from FDA More Likely for Drugs & Biologics Indicated for Pediatric Use?

    October 8, 2010
    Is a REMS Request From FDA More Likely For Drugs and Biologics Indicated for Pediatric Use?

  • Advancing Oncology Care Through Innovative Treatment Approaches

    September 22, 2010
    In this new white paper, Quintiles’ oncology experts Harish Dave and Eric Groves summarize the new findings and promising results presented at the June ASCO 2010 meeting.

  • Managing Pharmacovigilance as a Business

    July 28, 2010
    The three steps required to develop a strategic approach to global capacity management.

Page 1 of 2 (16 results)

Subscribe to Email Based on Your Interests

Set preferences